https://www.investors.com/news/technology/metsera-novo-nordisk-pfizer-acquisition/
0
0
10/30/25 at 9:09pm
Organization
Investor's Business Daily
39 words
0
Comments
Novo Nordisk kicked off a battle with Pfizer on Thursday, making an unsolicited $6.5 billion bid for obesity-focused Metsera.
You are the first to view
Create an account
or login to join the discussion